Partner Shabbi Khan was quoted in a Corporate Counsel article, “Challenges in Implementing AI Include Staffing and Knowing What to Use It for,” about the challenges legal departments face as they work to implement artificial intelligence and machine learning technology.
Khan said a lot of companies are paying top dollar to have data scientists do very specific jobs, which dissuades them from creating their own companies and stifles innovation. “It’s hard to find enough talent for a given vertical who are equipped to handle these machine learning types of environments,” he said.
One of the reasons in-house legal departments are not creating their own artificial intelligence programs is the expense, he added. “As a company your argument is that ‘we might save costs,’ but you have to spend $100,000 to find out if you’ll save anything,” he said. “It is not a low-cost implementation.”
Khan said a lot of companies are paying top dollar to have data scientists do very specific jobs, which dissuades them from creating their own companies and stifles innovation. “It’s hard to find enough talent for a given vertical who are equipped to handle these machine learning types of environments,” he said.
One of the reasons in-house legal departments are not creating their own artificial intelligence programs is the expense, he added. “As a company your argument is that ‘we might save costs,’ but you have to spend $100,000 to find out if you’ll save anything,” he said. “It is not a low-cost implementation.”
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.